Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · Franklin Templeton

Franklin International Core Equity (IU) Fund (FCENX)

Ticker FCENX · Since 2019-08-19 · · Holdings as of Jul 31, 2026

Expense ratio
0%$0/yr per $10k
5-yr return
+5.7%annualized
1-yr return
+5.1%as of Dec 2024
Net assets
$366.5Mall share classes
Holdings
218

Bottom line

Is FCENX a good fund? The bottom line

FCENX is an actively managed international stock mutual fund from Franklin Templeton.

Annual fees run 0% — about $0 a year on every $10,000 invested, cheaper than 99% of international stock funds we track.

It returned +5.1% over one year, +5.7% a year over five years (as of Dec 31, 2024, per its prospectus).

With $367 million in net assets and 218 holdings, its largest position is ASML Holding NV (2.8%) and the top 10 make up 19.4% of the portfolio.

What stands out

  • Low cost: cheaper than 99% of international stock peers
  • Broadly diversified (218 holdings)

Updated Nov 19, 2026

What FCENX invests in

The Funds investment goal is capital appreciation.

"Under normal market conditions, the Fund invests at least 80% of its net assets in equity securities. The Fund intends to invest predominantly in non-U.S. issuers. The Fund may invest in equity securities of any capitalization and primarily invests in common stock, but may also invest in depositary receipts. The Fund's investable universe typically includes equity securities of companies in the MSCI EAFE index. The Fund invests in both growth and value stocks, or in stocks with characteristics of both (""core"" style of investing). The investment manager employs a multi-factor selection process that includes using a proprietary model to assign a quantitative factor score for each issuer in the Funds investible universe based on that issuers exposure to quality, value, momentum, alternative factors and conviction factors. Each security is then further analyzed based on the assigned…

From the fund's prospectus (filed Nov 26, 2025).

FCENX performance

Fund calendar-year total returns, 2020–2024 2020: +9.4%; 2021: +15.0%; 2022: −17.3%; 2023: +20.7%; 2024: +5.1% +9.4% 2020 +15.0% 2021 −17.3% 2022 +20.7% 2023 +5.1% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FCENX+5.1%+5.7%—
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2024

Full FCENX performance history →

What FCENX costs

On a $10,000 investment, FCENX's 0% expense ratio costs about $0 a year. The prospectus estimates $60 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full FCENX fee table →

FCENX top 10 holdings

#Holding% of fund
1ASML Holding NV2.76%
2HSBC Holdings plc2.66%
3Novartis AG2.13%
4Mitsubishi UFJ Financial Group, Inc.2.09%
5Roche Holding AG1.91%
6Sony Group Corp.1.62%
7BNP Paribas SA1.61%
8ABB Ltd.1.58%
9Safran SA1.56%
10ING Groep NV1.51%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 19.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to FCENX

More funds like FCENX →

FCENX FAQ

What is the expense ratio of FCENX?
FCENX's expense ratio is 0%, which works out to about $0 a year for every $10,000 invested. The prospectus estimates total costs of $60 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FCENX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 99% of international stock peers; broadly diversified (218 holdings). This is general information, not personalized advice.
What does FCENX hold?
FCENX's largest holdings are ASML Holding NV (2.8%), HSBC Holdings plc (2.7%), Novartis AG (2.1%), Mitsubishi UFJ Financial Group, Inc. (2.1%), Roche Holding AG (1.9%). It holds 218 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is FCENX's 5-year return?
FCENX returned +5.7% a year over the five years ending Dec 31, 2024. Past performance does not guarantee future results.
Who manages FCENX?
FCENX is offered by Franklin Templeton through Franklin Fund Allocator Series.